Cargando…

Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics

As a main digestive organ and an important immune organ, the intestine plays a vital role in resisting the invasion of potential pathogens into the body. Intestinal immune dysfunction remains important pathogenesis of inflammatory bowel disease (IBD). In this review, we explained the interactions am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Quan, Yang, Mei-feng, Liang, Yu-jie, Xu, Jing, Xu, Hao-ming, Nie, Yu-qiang, Wang, Li-sheng, Yao, Jun, Li, De-feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928114/ https://www.ncbi.nlm.nih.gov/pubmed/35310454 http://dx.doi.org/10.2147/JIR.S353038

Ejemplares similares

New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease
por: Xu, Jing, et al.
Publicado: (2022)

Plant-derived exosomal nanoparticles: potential therapeutic for inflammatory bowel disease
por: Li, De-feng, et al.
Publicado: (2023)

Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease
por: Li, De-feng, et al.
Publicado: (2022)

Mesenchymal Stem Cell-derived Exosomes: Novel Therapeutic Approach for Inflammatory Bowel Diseases
por: Tian, Cheng-mei, et al.
Publicado: (2023)

Stem Cell Therapy in Inflammatory Bowel Disease: A Review of Achievements and Challenges
por: Tian, Cheng-Mei, et al.
Publicado: (2023)

Therapeutic potential of gene therapy for gastrointestinal diseases: Advancements and future perspectives
por: Yue, Ning-ning, et al.
Publicado: (2023)

Epigenetic DNA methylation of Zbtb7b regulates the population of double-positive CD4(+)CD8(+) T cells in ulcerative colitis
por: Xu, Hao-ming, et al.
Publicado: (2022)

Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease
por: Long, Xiong-Quan, et al.
Publicado: (2023)

Altered Pattern of Immunoglobulin A-Targeted Microbiota in Inflammatory Bowel Disease After Fecal Transplantation
por: Huang, Wen-qi, et al.
Publicado: (2022)

The Immunological Basis of Inflammatory Bowel Disease
por: Silva, Francesca A. R., et al.
Publicado: (2016)

Immunological pathogenesis of inflammatory bowel disease
por: Lee, Seung Hoon, et al.
Publicado: (2018)

Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities
por: Li, De‐feng, et al.
Publicado: (2023)

MYO9B gene polymorphisms are associated with the risk of inflammatory bowel diseases
por: Wang, Ming-Jie, et al.
Publicado: (2016)

Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease
por: Mao, Fei, et al.
Publicado: (2017)

Adipokine-Modulated Immunological Homeostasis Shapes the Pathophysiology of Inflammatory Bowel Disease
por: Tsai, Yi-Wen, et al.
Publicado: (2020)

Therapeutic drug monitoring in inflammatory bowel disease treatments
por: Wang, Meng-Yao, et al.
Publicado: (2022)

Different therapeutic approaches on quality of life in patients with inflammatory bowel disease
por: Xu, Junjie, et al.
Publicado: (2014)

Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses
por: Chen, Jie, et al.
Publicado: (2023)

Role of Pyroptosis in Inflammatory Bowel Disease (IBD): From Gasdermins to DAMPs
por: Zhang, Shuxia, et al.
Publicado: (2022)

Immunological Networks Defining the Heterogeneity of Inflammatory Bowel Diseases
por: Selin, Katja A, et al.
Publicado: (2021)

Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4(+)CD8(+)T cells expansion
por: Zhu, Min-zheng, et al.
Publicado: (2023)

Application of Nanoparticles in the Diagnosis of Gastrointestinal Diseases: A Complete Future Perspective
por: Yue, Ning-ning, et al.
Publicado: (2023)

Inflammasome-targeting natural compounds in inflammatory bowel disease: Mechanisms and therapeutic potential
por: Xu, Qiuyun, et al.
Publicado: (2022)

Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease
por: Sun, Jing, et al.
Publicado: (2016)

Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study
por: Yu, Qiao, et al.
Publicado: (2021)

Biological Activities Underlying the Therapeutic Effect of Quercetin on Inflammatory Bowel Disease
por: Lyu, Yong-Li, et al.
Publicado: (2022)

Increased expression of chymase in inflammatory polyps in elderly patients with functional bowel disorder
por: RONG, JIAN-MING, et al.
Publicado: (2014)

Fecal lactoferrin in discriminating inflammatory bowel disease from Irritable bowel syndrome: a diagnostic meta-analysis
por: Zhou, Xing-lu, et al.
Publicado: (2014)

Therapeutic Effect of Amomum villosum on Inflammatory Bowel Disease in Rats
por: Chen, Zhu, et al.
Publicado: (2018)

Intestinal Macrophage Autophagy and its Pharmacological Application in Inflammatory Bowel Disease
por: Zheng, Yang, et al.
Publicado: (2021)

Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease
por: Xu, Qiuyun, et al.
Publicado: (2021)

Therapeutic effects of lentinan on inflammatory bowel disease and colitis‐associated cancer
por: Liu, Yanrong, et al.
Publicado: (2018)

Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease
por: Fan, Fei-Yan, et al.
Publicado: (2017)

miR-802 participates in the inflammatory process of inflammatory bowel disease by suppressing SOCS5
por: Yao, Jun, et al.
Publicado: (2020)

Immunological and inflammatory profiles in mild and severe cases of COVID-19
por: Song, Jin-Wen, et al.
Publicado: (2020)

Effects of emodin on inflammatory bowel disease-related osteoporosis
por: Luo, Jing-sheng, et al.
Publicado: (2020)

Insights into the molecular mechanisms and therapeutic implications of interleukin-6 for inflammatory bowel disease
por: Tie, Yizhe, et al.
Publicado: (2023)

Prospective study of immunological factors in non-inflammatory bowel disease enterocutaneous fistulas
por: Rahbour, Goher, et al.
Publicado: (2011)

Oral Administration of Therapeutic Enzyme Capsule for the Management of Inflammatory Bowel Disease
por: Liang, Xiao, et al.
Publicado: (2022)

Effects of Deoxyschisandrin on Visceral Sensitivity of Mice with Inflammatory Bowel Disease
por: Xu, Zhili, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nj60oq3br7s0r45irobtm988cn